• LAST PRICE
    0.4900
  • TODAY'S CHANGE (%)
    Trending Down-0.0538 (-9.8933%)
  • Bid / Lots
    0.3707/ 10
  • Ask / Lots
    0.5354/ 7
  • Open / Previous Close
    0.5275 / 0.5438
  • Day Range
    Low 0.4473
    High 0.5400
  • 52 Week Range
    Low 0.3340
    High 1.5900
  • Volume
    66,389
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 0.5438
TimeVolumeSLGL
09:32 ET18180.5275
09:48 ET10910.54
09:59 ET2000.53988
10:15 ET2380.528
10:19 ET10000.511651
10:32 ET19060.4834
10:35 ET14030.4482
10:37 ET30560.4479
10:39 ET8000.44745
10:42 ET6000.4475
10:44 ET1110.456
10:50 ET3000.4558
10:51 ET7470.455
10:53 ET1000.4501
10:55 ET14240.454399
11:02 ET24530.4517
11:13 ET70000.4695
11:15 ET3000.4517
11:40 ET31000.4695
11:42 ET70000.4694
11:47 ET18330.45
11:51 ET30000.4694
12:02 ET23500.4742
12:20 ET20500.4742
12:43 ET7560.519612
12:54 ET1000.5222
01:06 ET3400.5364
02:38 ET1000.5133
02:56 ET1120.5133
03:03 ET20000.5135
03:07 ET2000.5136
03:21 ET2000.5135
03:27 ET50000.5133
03:38 ET1000.5081
03:43 ET2300.508
03:45 ET21400.5081
03:48 ET1000.4911
03:50 ET10000.4948
03:52 ET1000.4948
03:54 ET81200.4922
03:59 ET7460.49
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSLGL
Sol Gel Technologies Ltd
15.1M
-0.9x
---
United StatesLYRA
Lyra Therapeutics Inc
17.8M
-0.2x
---
United StatesDOMH
Dominari Holdings Inc
10.7M
-0.4x
---
United StatesADXN
Addex Therapeutics Ltd
16.4M
-0.8x
---
United StatesTGRP
Tron Pharmaceuticals Inc
7.3M
-11.2x
---
United StatesMTNB
Matinas BioPharma Holdings Inc
9.7M
-0.1x
---
As of 2024-10-31

Company Information

Sol-Gel Technologies Ltd is a clinical-stage dermatology company. The Company is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The Company is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.

Contact Information

Headquarters
Golda Meir 7NESS-ZIONA, Israel 7403650
Phone
---
Fax
---

Executives

Executive Chairman of the Board
Moshe Arkin
Chief Executive Officer, Co-Founder, Director
Alon Seri-Levy
Chief Financial Officer
Eyal Ben-Or
Vice President - Operations
Itzik Yosef
Vice President - Quality
Nissim Bilman

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$15.1M
Revenue (TTM)
$6.6M
Shares Outstanding
27.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.57
EPS
$-0.54
Book Value
$1.39
P/E Ratio
-0.9x
Price/Sales (TTM)
2.3
Price/Cash Flow (TTM)
---
Operating Margin
-256.17%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.